321 related articles for article (PubMed ID: 15131791)
1. Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
Afdhal NH; Dieterich DT; Pockros PJ; Schiff ER; Shiffman ML; Sulkowski MS; Wright T; Younossi Z; Goon BL; Tang KL; Bowers PJ;
Gastroenterology; 2004 May; 126(5):1302-11. PubMed ID: 15131791
[TBL] [Abstract][Full Text] [Related]
2. Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy.
Pockros PJ; Shiffman ML; Schiff ER; Sulkowski MS; Younossi Z; Dieterich DT; Wright TL; Mody SH; Tang KL; Goon BL; Bowers PJ; Leitz G; Afdhal NH;
Hepatology; 2004 Dec; 40(6):1450-8. PubMed ID: 15565613
[TBL] [Abstract][Full Text] [Related]
3. Role of epoetin alfa in maintaining ribavirin dose.
Afdhal NH
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S25-35. PubMed ID: 15081101
[TBL] [Abstract][Full Text] [Related]
4. Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa.
Dieterich DT; Wasserman R; Bräu N; Hassanein TI; Bini EJ; Bowers PJ; Sulkowski MS
Am J Gastroenterol; 2003 Nov; 98(11):2491-9. PubMed ID: 14638354
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C.
Bräu N
J Viral Hepat; 2004 May; 11(3):191-7. PubMed ID: 15117320
[TBL] [Abstract][Full Text] [Related]
6. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.
Hudis CA; Vogel CL; Gralow JR; Williams D;
Clin Breast Cancer; 2005 Jun; 6(2):132-42. PubMed ID: 16001991
[TBL] [Abstract][Full Text] [Related]
7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
Voravud N; Sriuranpong V; Suwanrusme H
J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients.
Levine AM; Salvato P; Leitz GJ;
AIDS Res Hum Retroviruses; 2008 Feb; 24(2):131-9. PubMed ID: 18284320
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis.
Bertino G; Ardiri A; Boemi PM; Calvagno GS; Ruggeri IM; Speranza A; Santonocito MM; Ierna D; Bruno CM; Valenti M; Boemi R; Naimo S; Neri S
Eur J Clin Pharmacol; 2010 Oct; 66(10):1055-63. PubMed ID: 20652232
[TBL] [Abstract][Full Text] [Related]
10. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients.
Saag MS; Bowers P; Leitz GJ; Levine AM;
AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1037-45. PubMed ID: 15587490
[TBL] [Abstract][Full Text] [Related]
11. Ifn/Rbv treatment induced anemia and its correction with epoetin alpha in patients with hepatitis C.
Sharvadze L; Tsertsvadze T; Gochitashvili N; Kakabadze T; Dolmazashvili E
Georgian Med News; 2006 Aug; (137):62-5. PubMed ID: 16980747
[TBL] [Abstract][Full Text] [Related]
12. Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.
Sherman M; Cohen L; Cooper MA; Elkashab M; Feinman V; Fletcher D; Girgrah N; Heathcote J; Levstik M; McNaull WB; Wong D; Wong F; Yim C
Can J Gastroenterol; 2006 Jul; 20(7):479-85. PubMed ID: 16858501
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin.
Balan V; Schwartz D; Wu GY; Muir AJ; Ghalib R; Jackson J; Keeffe EB; Rossaro L; Burnett A; Goon BL; Bowers PJ; Leitz GJ;
Am J Gastroenterol; 2005 Feb; 100(2):299-307. PubMed ID: 15667486
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
Cortesi E; Mancuso A; De Pasquale Ceratti A; Pizzardi N; D'Auria G; Accettura C; Beccaglia P; Bertelletti D; De Marinis F
Oncologist; 2004; 9(4):459-68. PubMed ID: 15266099
[TBL] [Abstract][Full Text] [Related]
16. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
Voravud N; Sriuranpong V
J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
[TBL] [Abstract][Full Text] [Related]
18. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
[TBL] [Abstract][Full Text] [Related]
19. Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.
Vispo E; Labarga P; Guardiola JM; Barreiro P; Miralles C; Rubio R; Miralles P; Aguirrebengoa K; Portu J; Morello J; Rodriguez-Novoa S; Soriano V;
AIDS Res Hum Retroviruses; 2010 Apr; 26(4):419-24. PubMed ID: 20377423
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma.
Dammacco F; Castoldi G; Rödjer S
Br J Haematol; 2001 Apr; 113(1):172-9. PubMed ID: 11328297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
